Title : Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.

Pub. Date : 2016 Oct

PMID : 27448708






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Normal age-adjusted values of IGF-I were obtained in 48% of lanreotide/cabergoline-treated patients and 70% of lanreotide/pegvisomant-treated patients at EOS. pegvisomant insulin like growth factor 1 Homo sapiens